Dear Editor,
2,3
In particular, liver enzyme-inducing antiepileptic drugs (AEDs), i.e. phenobarbital, phenytoin, and carbamazepine, can cause SD by decreasing bioactive testosterone, accelerating sexual hormone metabolism, and stimulating binding hormone proteins production.
Conversely, new AEDs, including topiramate, zonisamide, oxcarbazepine, lamotrigine and pregabalin, are thought to cause SD through complex and poorly understood mechanisms. 4 Although Svalheim et al. 5 have demonstrated that LEV treatment apparently has no drug-specific sexual or endocrine side effects in men or women aged 45 years, a few case reports are emerging from the literature showing a possible correlation between SD and LEV ingestion. Indeed, alongside the interesting case of LEV-induced hypersexuality by Metin et al., we have recently reported two young men with epilepsy who experienced severe loss of libido and anhedonia after LEV intake. 6 Levetiracetam is a new AED exerting its antiepileptic effect through multiple and poorly understood mechanisms of action. Synaptic vesicle glycoprotein 2A vesicular membrane protein appears to be the main pharmacological target, but several effects on ion channels have been described, including blockade of highvoltage-activated Ca 2+ channels, modulation of K+ channels, and enhancement of GABA-and glycine-gated currents. In particular, LEV-induced inhibition of presynaptic P/Q-type calcium channels has been demonstrated to increase brainstem serotonin concentration in mice, with a consequent imbalance in dopamine/serotonin rate leading to alteration in emotion-related behaviour. 7 Thus, since LEV did not appear to alter the sex hormonal profile, other possible pathomechanisms leading to SD should be considered. Indeed, given that sexual desire and pleasure are mainly related to CNS dopamine levels, it is hypothesizable that LEV-induced loss of libido (as in the patient reported by our group) 6 or hypersexuality (as in the patient by Metin et al. 1 ) may be related to alterations in brain excitatory transmission (sexual drive and arousal) by unbalancing the dopamine/serotonin ratio.
In conclusion, as individuals with epilepsy may not spontaneously complain of SD, we recommend a wide assessment of their sexual function, because even new AEDs, including LEV, may cause sexual disorders through complex and still poorly understood neurobiological mechanisms.
